Home » Stocks » Nephros

Nephros, Inc. (NEPH)

Stock Price: $7.36 USD -0.24 (-3.16%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 66.45M
Revenue (ttm) 11.09M
Net Income (ttm) -3.17M
Shares Out 9.03M
EPS (ttm) -0.40
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 10, 2020
Last Price $7.36
Previous Close $7.60
Change ($) -0.24
Change (%) -3.16%
Day's Open 7.69
Day's Range 7.33 - 7.69
Day's Volume 8,448
52-Week Range 4.42 - 11.35

More Stats

Market Cap 66.45M
Enterprise Value 60.06M
Earnings Date (est) Aug 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 9.03M
Float 4.30M
EPS (basic) -0.39
EPS (diluted) -0.40
FCF / Share -0.40
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 7,537
Short Ratio 0.62
Short % of Float 0.09%
Beta 1.29
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 5.99
PB Ratio 6.87
Revenue 11.09M
Operating Income -3.07M
Net Income -3.17M
Free Cash Flow -3.43M
Net Cash 6.39M
Net Cash / Share 0.71
Gross Margin 54.84%
Operating Margin -27.65%
Profit Margin -28.60%
FCF Margin -30.94%
ROA -13.49%
ROE -30.44%
ROIC -55.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(92.53% upside)
Current: 7.36
Target: 14.17
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth81.71%49.3%64.18%19.34%11.21%0.46%-3.71%-18.38%-24.64%-
Gross Profit6.
Operating Income-3.31-3.02-2.23-2.87-3.42-2.67-3.31-3.28-2.31-1.89
Net Income-3.42-3.40-0.81-3.03-3.09-7.371.32-3.26-2.36-1.93
Shares Outstanding7.546.855.885.403.862.651.741.250.960.23
Earnings Per Share-0.45-0.50-0.18-0.54-0.81-2.79-1.62-2.61-2.43-8.37
Operating Cash Flow-2.28-3.66-0.08-2.11-3.82-2.50-3.58-1.55-1.30-1.29
Capital Expenditures-0.01---0.05-0.01--0.05--0.03
Free Cash Flow-2.29-3.66-0.08-2.16-3.83-2.50-3.58-1.50-1.30-1.32
Cash & Equivalents4.174.582.210.301.251.280.580.051.670.24
Total Debt2.552.031.670.84--1.36--0.50
Net Cash / Debt1.622.550.55-0.541.251.28-0.780.051.67-0.26
Book Value4.683.801.950.672.66-5.68-3.72-0.601.420.14
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Nephros, Inc.
Country United States
Employees 25
CEO Daron G. Evans

Stock Information

Ticker Symbol NEPH
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: NEPH
IPO Date September 21, 2004


Nephros, Inc., a commercial stage medical device and commercial product company, develops and sells liquid purification filters and hemodiafiltration (HDF) systems primarily in the United States. It operates through two segments, Water Filtration and Renal Products. The company's ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from water borne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It offers HDF systems for use in conjunction with a hemodialysis machine that enables nephrologists to provide HDF treatment to patients with end stage renal disease; hemodiafilters for use as dialyzers in hemodialysis treatment; and water filters to food service, hospitality, and convenience store markets under the AETHER brand name. The company was founded in 1997 and is headquartered in South Orange, New Jersey.